In-House Impact: Life Sciences is a new type of forum, designed for and by legal leaders in the Life Sciences, to help legal teams move from enterprise defenders to enablers of innovation and cross-functional competency.
This conference isn’t just unique in offering an industry-specific platform for the most progressive legal leaders to maximize their own business value; it’s also unique in that it rips up the rulebook of traditional conferences.
We guarantee that your time out of the office and money are well spent. With thought-provoking case studies, action-led discussions and ensuring every story shared is evidenced by the business improvement it delivers, we’ve no doubt this strategic discussion will leave you feeling inspired to make big change.
In-House Impact works because it connects you with the most forward-thinking legal leaders taking the most radical steps to maximize the business value they add as strategic business partners.
We believe the traditional conference format is no longer fit for purpose, so we started from scratch. Here’s how it works:
When you look at the event agenda, you will see three main types of session:
* Discover sessions: Hear the boldest legal leaders in Life Sciences sharing the stories of what they’re doing to maximize the impact of their team
* Develop sessions: Have your burning questions answered in a room full of your peers and move beyond the ‘what’ and the ‘why’ to get to the ‘how’
* Action sessions: Audience is divided by same-level seniority to help you discuss challenges with peers, and decide what you are going to change in order to add as much value to the business
In-House Impact: Life Sciences is a new event, both designed by and for General Counsels of Life Sciences companies, from smaller start-ups to large pharmaceuticals.
Price: 2-Day Conference Pass: USD 2499.00
Speakers: Marcela Kirberger, Roche Diagnostics Corporation, Maurus Schreyvogel, Novartis, Beth Zelnick-Kaufman, The Broad Institute of MIT and Harvard, Eric Sherbet, IQVIA, Christine Pellizzari, Insmed, Jonathan Biller, Agios Pharmaceuticals, Paul Savidge, Spark Therapeutics, John Ryan, The Jackson Laboratory, Lisa Matovcik, GSK, Laurie Keating, Alnylam Pharmaceuticals, Richard Rew, Luminex Corporation, Heather Goodman, Two Labs Pharma Services, Shaun Ryan, Moderna, Christine Bellon, Beam Therapeutics, Ethan Knowlden, Medicines360, Dina Ciarimboli, Third Rock Ventures, Peter Daniels, Hanson Wade
Time: 9:00 am to 6:00 pm